Lack of continuum between cerebral aging and Alzheimer's disease as revealed by PHF-tau and Aβ biochemistry

Alzheimer's Reports

Volumn 1, Issue 2, 1998, Pages 101-110

  Delacourte, André ^a   Buée, Luc ^a   David, Jean Philipe ^a,c   Sergeant, Nicolas ^a   Wattez, Annick ^a   Vermersch, Patrick ^a   Pasquier, Florence ^b   Lebert, Florence ^b   Ghozali, Farida ^c   Fallet Bianco, Catherine ^c   Di Menza, Claude ^c  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c Hôpitaux Universitaires Henri Mondor   (France)

Author keywords

Aging; Alzheimer's disease; Brodmann areas; Examination; Mini mental state; Neurofibrillary tangles; PHF tau

Indexed keywords

EID: 0000500483     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Barelli HL, Lebeau A, Vizzavona J et al. (1997). Characterization of a new polclonal antibody specific for 40 and 42 amino acid long amyloid beta peptides. Mol Med 3, 695-707.
2. Benton AL (1981). J Clin Neuropsychol 3, 33-42.
3. Bouras C, Hof PR, Giannakopoulos P et al. (1994). Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients - a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cerebr Cortex 4, 138-150.
4. Bowen DM, Francis PT, Procter AW et al. (1992). Treatment strategy for the corticocortical neuronal pathology of Alzheimer's disease. Ann Neurol 32, 112.
5. Braak H & Braak E (1995). Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 16, 271-278.
6. Braak H & Braak E (1997). Aspects of cortical destruction in Alzheimer's disease. Research and Perspectives in Alzheimer's disease. In: Hyman BT, Duyckaerts C & Christen Y, eds. Connections, cognition and Alzheimer's disease. Springer-Verlag, Berlin: 1-16.
7. Buée-Scherrer V, Conamines O, Mourtongilles C et al. (1996). AD 2, A phosphorylation-dependent monoclonal antibody directed against tau protein found in Alzheimer's disease. Mol Brain Res 39, 79-88.
8. Delacourte A & Buée L (1997). Normal and pathological tau proteins as factors for microtubule assembly. Int Rev Cytol 171, 167-224.
9. Duyckaerts C, Bennecib M, Grignon Y et al. (1997). Modelling the relations between neurofibrillary tangles and intellectual status. Neurobiol Aging 18, 267-73.
10. Folstein MR, Folstein SC & McHugh G (1975). Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
11. Forsell Y, Jorm AF, Fratiglioni L et al. (1993). Application of DSM-III-R criteria for major depressive episode to elderly subjects with and without dementia. Am J Psychiatr 150, 1199-1202.
12. Helmes E, Merskey H, Fox H et al. (1995). Patterns of deterioration in senile dementia of the Alzheimer-type. Arch Neurol 52, 306-310.
13. Hof PR et al. (1997). Morphologic and neurochemical characteristics of corticocortical projections, emergence of circuit-specific features and relationships to degenerative changes in Alzheimer's disease. Research and Perspectives in Alzheimer's disease. Hyman BT, Duyckaerts C, Christen Y, eds. Connections, cognition and Alzheimer's disease. Springer-Verlag, Berlin:59-82.
14. Hughes CP, Berg L, Danziger WL et al. (1982). A new clinical scale for the staging of dementia. Br J Psychiatr 140, 566-572.
15. Jellinger KA (1995). Alzheimer's changes in non demented and demented patients. Acta Neuropathol 89, 112-113.
16. McKhann GM, Drachman D, Folstein M et al. (1984). Clinical diagnosis of Alzheimer's disease - Report of the NINCDS-ADRDA work group. Neurology 34, 939-944.
17. Mirra SS, Heyman A, McKeel D et al. (1991). The consortium to establish a registry for Alzheimer's disease (CERAD) 2. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
18. Morrison JH and Hof PR (1997). Life and death of neurons in the aging brain. Science 278, 412-419.
19. Permanne B, Buée L, David JP et al. (1995). Alzheimer's disease - Aβ or ApoE amyloidosis. Brain Res 685, 154-162.
20. Roman GC, Tatemichi TK, Erkinjuntti T et al. (1993). Vascular dementia - Diagnosis criteria for research studies - Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
21. Selkoe DJ (1997). Neuroscience - Alzheimer's disease: Genotypes, phenotype and treatments. Science 275, 630-631.
22. Sergeant N, David JP, Goedert M et al. (1997). Two-dimensional characterisation of paired helical filament-tau from Alzheimer's disease: Demonstration of an additional 74kDa component and age-related biochemical modifications. J Neurochem 69, 834-844.
23. Vermersch P, Frigard B and Delacourte A (1992). Mapping of neurofibrillary degeneration in Alzheimer's disease - evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathol 85, 48-54.
24. Vermersch P, David JP, Frigard B et al. (1995). Cortical mapping of Alzheimer pathology in brains of aged non demented subjects. Prog Neuropsychopharmacol Biol Psychiatr 19, 1035-1047.